Exact Mass: 580.0342852

Exact Mass Matches: 580.0342852

Found 24 metabolites which its exact mass value is equals to given mass value 580.0342852, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Uridine diphosphate glucuronic acid

(2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


Uridine diphosphate glucuronic acid, also known as udpglucuronate or udp-D-glucuronic acid, is a member of the class of compounds known as pyrimidine nucleotide sugars. Pyrimidine nucleotide sugars are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. Uridine diphosphate glucuronic acid is soluble (in water) and a moderately acidic compound (based on its pKa). Uridine diphosphate glucuronic acid can be synthesized from alpha-D-glucuronic acid. Uridine diphosphate glucuronic acid can also be synthesized into UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid. Uridine diphosphate glucuronic acid can be found in a number of food items such as parsley, chervil, black mulberry, and malabar plum, which makes uridine diphosphate glucuronic acid a potential biomarker for the consumption of these food products. Uridine diphosphate glucuronic acid can be found primarily in human liver tissue. Uridine diphosphate glucuronic acid exists in all living species, ranging from bacteria to humans. In humans, uridine diphosphate glucuronic acid is involved in several metabolic pathways, some of which include etoposide metabolism pathway, estrone metabolism, tamoxifen action pathway, and androgen and estrogen metabolism. Uridine diphosphate glucuronic acid is also involved in several metabolic disorders, some of which include porphyria variegata (PV), glycogenosis, type III. cori disease, debrancher glycogenosis, 17-beta hydroxysteroid dehydrogenase III deficiency, and hereditary coproporphyria (HCP). Uridine diphosphate glucuronic acid is made from UDP-glucose by UDP-glucose 6-dehydrogenase (EC 1.1.1.22) using NAD+ as a cofactor. It is the source of the glucuronosyl group in glucuronosyltransferase reactions . Uridine diphosphate glucuronic acid is a nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP Iduronic acid, which donates Iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. The transfer of glucuronic acid from UDP-alpha-D-glucuronic acid onto a terminal galactose residue is done by beta1,3-glucuronosyltransferases, responsible for the completion of the protein-glycosaminoglycan linkage region of proteoglycans and of the HNK1 epitope of glycoproteins and glycolipids. In humans the enzyme galactose-beta-1,3-glucuronosyltransferase I completes the synthesis of the common linker region of glycosaminoglycans (GAGs) by transferring glucuronic acid (GlcA) onto the terminal galactose of the glycopeptide primer of proteoglycans. The GAG chains of proteoglycans regulate major biological processes such as cell proliferation and recognition, extracellular matrix deposition, and morphogenesis. (PMID:16815917). Acquisition and generation of the data is financially supported in part by CREST/JST.

   

UDP-D-galacturonic acid

(2S,3R,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


UDP-D-galacturonic acid (UDP-GalA), belongs to the class of organic compounds known as pyrimidine nucleotide sugars. These are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. UDP-D-galacturonic acid is known to be formed by the 4-epimerization of UDP-D-glucuronic acid. UDP-D-galacturonic acid is an extremely weak basic (essentially neutral) compound (based on its pKa). Outside of the human body, UDP-D-galacturonic acid has been detected, but not quantified in, several different foods, such as peaches, apples, Cucurbita (gourd), agaves, and oats. This could make UDP-D-galacturonic acid a potential biomarker for the consumption of these foods. UDP-D-galacturonate, the activated form of this sugar, is known to be formed by the 4-epimerization of UDP-D-glucuronate. [HMDB]. UDP-D-galacturonate is found in many foods, some of which are japanese persimmon, borage, chives, and caraway.

   

UDP-L-iduronate

(2R,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


UDP-L-iduronate is converted from UDP-n-glucuronic acid. n-Iduronic and n-glucuronic acid have been identified as the hexuronic acid components of dermatan sulfate. UDP-Dglucose is the metabolic precursor of both uranic acids . Conversion of UDP-u-glucose to UDP-n-glucuronic acid and the subsequent C-5 inversion of UDP-n-glucuronic acid to UDP-Liduronic acid is catalyzed by extracts of mammalian tissues. However, UDP-n-iduronic acid has never been isolated and its role in the polymerization of L-iduronic acid-containing polymers has remained hypothetical. [HMDB] UDP-L-iduronate is converted from UDP-n-glucuronic acid. n-Iduronic and n-glucuronic acid have been identified as the hexuronic acid components of dermatan sulfate. UDP-Dglucose is the metabolic precursor of both uranic acids. Conversion of UDP-u-glucose to UDP-n-glucuronic acid and the subsequent C-5 inversion of UDP-n-glucuronic acid to UDP-Liduronic acid is catalyzed by extracts of mammalian tissues. However, UDP-n-iduronic acid has never been isolated and its role in the polymerization of L-iduronic acid-containing polymers has remained hypothetical.

   

(2R,3R,4R,5S,6R)-6-[[[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3R,4R,5S,6R)-6-[[[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


   

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

[({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-3-[(3,4,5,6-tetrahydroxy-2-oxohexanoyl)oxy]oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C15H22N2O18P2 (580.0342852)


   

Uridine 5-diphosphoglucuronic acid

Uridine 5-diphosphoglucuronic acid

C15H22N2O18P2 (580.0342852)


   

Uridine-5′-diphosphoglucuronic acid trisodium salt

Uridine-5′-diphosphoglucuronic acid trisodium salt

C15H22N2O18P2 (580.0342852)


   

Uridine diphosphate glucuronic acid

Uridine diphosphate glucuronic acid

C15H22N2O18P2 (580.0342852)


   

Uridine-5-diphosphate glucuronic acid

Uridine-5-diphosphate glucuronic acid

C15H22N2O18P2 (580.0342852)


   

URIDINE 5'-DIPHOSPHOGLUCURONIC ACID

URIDINE 5'-DIPHOSPHOGLUCURONIC ACID

C15H22N2O18P2 (580.0342852)


   

L-HISTIDINE,N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-1-[(4-METHYLPHENYL)SULFONYL]-

L-HISTIDINE,N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-1-[(4-METHYLPHENYL)SULFONYL]-

C25H20N6O7S2 (580.0834850000001)


   

Sarolaner

Sarolaner

C23H18Cl2F4N2O5S (580.0249566)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent

   

1-Amino-9,10-dioxo-4-[4-(2-sulfonatooxyethylsulfonyl)anilino]anthracene-2-sulfonate

1-Amino-9,10-dioxo-4-[4-(2-sulfonatooxyethylsulfonyl)anilino]anthracene-2-sulfonate

C22H16N2O11S3-2 (579.9916225999999)


   

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3S,4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoate

C15H22N2O18P2 (580.0342852)


   

(2S,3S,4S,5R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


   
   

UDP-alpha-D-mannuronic acid

UDP-alpha-D-mannuronic acid

C15H22N2O18P2 (580.0342852)


   

[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C16H26N2O17P2 (580.0706686000001)


   

(2S,3S,4S,5R,6R)-6-[[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-6-[[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)


   
   

UDP-alpha-D-galacturonic acid

UDP-alpha-D-galacturonic acid

C15H22N2O18P2 (580.0342852)


   

UDP-alpha-D-Glucuronic acid

UDP-alpha-D-Glucuronic acid

C15H22N2O18P2 (580.0342852)


A UDP-sugar having alpha-D-glucuronic acid as the sugar component.

   

bPiDI

bPiDI

C22H34I2N2 (580.0811384000001)


bPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs[1].

   

(2s,3r,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3r,4s,5r,6r)-6-[({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H22N2O18P2 (580.0342852)